Additional InformationTHE PHARMACEUTICAL MARKET: PERU - REVIEW
The Peruvian pharmaceutical market is the second smallest in the region. The market is expected to increase by a moderate CAGR in dollar terms between 2011 and 2016. Pharmaceutical expenditure per capita is the lowest in the region. This means that there are growth opportunities, as the economy is expected to perform well in the forecast period. The market increased five times between 1995 and 2010. In January 2011, the Israeli company Teva Pharmaceutical Industries announced that it was acquiring Infarmasa from The Rohatyn Group (TRG) and Altra Investments. Teva commented that the combination of Medco, which is Teva’s existing operation in Peru, and Infarmasa would create one of the top two pharmaceutical companies in the country.
Peru is often overlooked when discussing the rapid-growth economies of South America. While it has neither the size nor the wealth of Brazil or Argentina, the country has a population that exceeds 30 million in 2011, and has recorded strong economic growth in recent years. According to the Economist Intelligence Unit (EIU), GDP growth increased by 6.5% in real terms in 2011. GDP per capita wealth has risen, especially around Lima, leading to a sizeable urban population that demands improved healthcare and has the ability to pay for it. This economic environment is expected to encourage drug consumption. In legal terms, Peru is continuing to implement its National Strategic Plan to combat counterfeiting and piracy.
Major Peruvian pharmaceutical wholesalers include Química Suiza, Albis and Drokasa. Química Suiza imports, produces, markets and distributes pharmaceuticals, personal care products and equipment for the industrial sector. The company has offices in Arequipa, Chiclayo, Cusco, Huancayo, Iquitos, Lima, Piura and Trujillo. Química Suiza also has a regional presence with subsidiaries in Bolivia, Colombia, Ecuador and Venezuela. The company has six divisions. In February 2011, Química Suiza acquired the pharmacy chain Boticas BTL for an undisclosed transaction value. With this acquisition, Química Suiza will control about 300 pharmacies in Peru; the company already owns Boticas Mifarma in the retail pharmacy sector.
ENHANCED STRATEGIC INTELLIGENCE
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.
More Prescription Drugs reports by Espicom Healthcare Intelligence
Understanding the US's Regional Healthcare Markets by Espicom Healthcare Intelligence
Understanding the US's Regional Healthcare Markets
For years to come, the US healthcare market will remain the most attractive to providers of medical services. Considerable ...
The Pharmaceutical Market: Brazil by Espicom Healthcare Intelligence
The Pharmaceutical Market: Brazil
OVERVIEW OF THE PHARMACEUTICAL MARKET IN BRAZIL The Brazilian pharmaceutical market remains our favourite regional market in Latin America due to ...
Inhalation & Nasal Spray Generic Drugs 2013 by Espicom Healthcare Intelligence
Inhalation & Nasal Spray Generic Drugs 2013
Around three quarters of the US$36.4 billion respiratory prescription drugs market comprises drugs that are delivered using inhalation ...
See all reports like this >>
Middle East North Africa Pharmaceutical Market Forecasts to 2018 by Espicom Healthcare Intelligence
Middle East North Africa Pharmaceutical Market Forecasts to 2018
The global pharmaceutical market is forecast to be worth over US$1,250 billion by 2018 - but ...
More Peru Prescription Drugs reports
Peru Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Peru Pharmaceuticals and Healthcare Report Q2 2015BMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for qualitycontrol will continue to ...
Pharmaceuticals and Healthcare : Peru Pharmaceuticals and Healthcare Report Q3 2014 by Business Monitor International
Pharmaceuticals and Healthcare : Peru Pharmaceuticals and Healthcare Report Q3 2014BMI View: Although per capita medicine spending in Peru is among the lowest in Latin ...
Antibiotics Market in Peru to 2016 by Global Research & Data Services Oy
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Peru. The study provides essential market ...
See all reports like this >>
The Pharmaceutical Market: Peru by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...